Orange Book Over-Declaration Of Pharmaceutical Patents: The Advantages Of Ex Ante Over Ex Post Review
Publication
, Other
Rai, AK; Contreras, JL
Published in: Health Affairs Forefront
2023
Duke Scholars
Published In
Health Affairs Forefront
Publication Date
2023
Citation
APA
Chicago
ICMJE
MLA
NLM
Rai, A. K., & Contreras, J. L. (2023). Orange Book Over-Declaration Of Pharmaceutical Patents: The Advantages Of Ex Ante Over Ex Post Review. Health Affairs Forefront.
Rai, Arti K., and Jorge L. Contreras. “Orange Book Over-Declaration Of Pharmaceutical Patents: The Advantages Of Ex Ante Over Ex Post Review.” Health Affairs Forefront, 2023.
Rai AK, Contreras JL. Orange Book Over-Declaration Of Pharmaceutical Patents: The Advantages Of Ex Ante Over Ex Post Review. Health Affairs Forefront. 2023.
Rai, Arti K., and Jorge L. Contreras. “Orange Book Over-Declaration Of Pharmaceutical Patents: The Advantages Of Ex Ante Over Ex Post Review.” Health Affairs Forefront, 2023.
Rai AK, Contreras JL. Orange Book Over-Declaration Of Pharmaceutical Patents: The Advantages Of Ex Ante Over Ex Post Review. Health Affairs Forefront. 2023.
Published In
Health Affairs Forefront
Publication Date
2023